TOBREX

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey.

Active ingredients

The drug TOBREX contains one active pharmaceutical ingredient (API):

1	Tobramycin UNII VZ8RRZ51VK - TOBRAMYCIN
	Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations.
	Read more about Tobramycin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TOBREX 0.3% Ophthalmic ointment	MPI, US: SPL/Old	FDA, National Drug Code (US)
TOBREX 0.3% Ophthalmic solution	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AA12	Tobramycin	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2328M, 2329N, 5569D, 5570E
BR	Câmara de Regulação do Mercado de Medicamentos	500903701164311, 500903702179310
CA	Health Products and Food Branch	00513962, 00614254
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.213-03-05
EE	Ravimiamet	1012543, 1150120, 1730821, 1870589, 1870758
ES	Centro de información online de medicamentos de la AEMPS	57593, 57594
FI	Lääkealan turvallisuus- ja kehittämiskeskus	015638
FR	Base de données publique des médicaments	61621356, 67299307
HK	Department of Health Drug Office	17292, 19904
HR	Agencija za lijekove i medicinske proizvode	HR-H-257802614, HR-H-904981713
IL	מִשְׂרַד הַבְּרִיאוּת	6848, 756
LT	Valstybinė vaistų kontrolės tarnyba	1012608, 1016300, 1021386, 1066396, 1074798, 1076195, 1076968, 1079721, 1080369, 1082816, 1082817, 1087031, 1088699, 1091108
MT	Medicines Authority	MA1249/02901, MA1249/02902
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	74M83, 95M83
NG	Registered Drug Product Database	A4-1975
Switch country to Nigeria in order to find specific presentations of TOBREX
NL	Z-Index G-Standaard	12557676
NL	Z-Index G-Standaard, PRK	18376, 22373
NZ	Medicines and Medical Devices Safety Authority	3295, 3296
PL	Rejestru Produktów Leczniczych	100067053, 100165376, 100247619, 100267651, 100268260, 100277796, 100304895, 100305268, 100306463, 100316020, 100324930, 100325638, 100327519, 100343607, 100344535, 100344558, 100345463, 100357940, 100359695, 100362131, 100363107, 100384256, 100391552, 100394556, 100396615, 100423105, 100438176, 100438880, 100438897, 100440776, 100441592, 100442019, 100442048, 100447643, 100447650, 100448772, 100451790, 100452556, 100463217, 100468125
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63542001, W63543001
SG	Health Sciences Authority	04451P, 04722P
TN	Direction de la Pharmacie et du Médicament	10283391, 1028341
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504440522, 8699504612110
US	FDA, National Drug Code	0065-0643, 0065-0644
ZA	Health Products Regulatory Authority	P/15.1/205, P/15.1/58